N-(2-(3-CYANO-2-AZABICYCLO[3.1.0]HEXAN-2-YL)-2-OXOÉTHYL)- QUINOLÉINE-4-CARBOXAMIDESS
MA71235B1Active Publication Date: 2026-09-30ASTRAZENECA AB
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA71235
- Authority / Receiving Office
- MA · MA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2023-06-20
- Filing Date
- 2023-06-20
- Publication Date
- 2026-09-30
- Estimated Expiration
- 2043-06-20
Abstract
The invention relates to compounds having the structure of formula (I) and their pharmaceutically acceptable salts, in which R2, R3, R5, R6, R7, and R8 have the meanings given in the description; pharmaceutical compositions comprising such compounds and salts; the use of such compounds and salts to treat or prevent pathological conditions mediated by fibroblast-activating protein (FAP) prolyl-endopeptidase; kits comprising such compounds and salts; and methods for manufacturing such compounds and salts.
Need to check novelty before this filing date? Find Prior Art